"Dermatologist"

During the past decade, Dermatology Research Associates conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 47 clinical trials were completed, i.e. on average, 77% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 25 clinical trials were completed. i.e. 78.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dermatology Research Associates" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Amgen" with 10 trials sponsored, "Pfizer" with 7 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored and "Galderma R&D" with 5 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatology Research Associates" #1 collaborator was "Dermira, Inc." with 6 trials as a collaborator, "Accelovance" with 1 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "Dermatology Research Institute" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Dermatology Research Associates" are "Atopic Dermatitis" (20 trials), "Psoriasis" (15 trials), "Acne Vulgaris" (8 trials), "Plaque Psoriasis" (8 trials) and "Actinic Keratosis" (6 trials). Many other conditions were trialed in "Dermatology Research Associates" in a lesser frequency.

Most popular intervention types in "Dermatology Research Associates" are "Drug" (89 trials), "Other" (13 trials), "Biological" (8 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "Lebrikizumab" (8 trials), "Apremilast" (6 trials), "Vehicle" (6 trials) and "ASN002" (4 trials). Other intervention names were less common.

The vast majority of trials in "Dermatology Research Associates" are 97 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dermatology Research Associates". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 75 completed trials in Dermatology Research Associates, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Dermatology Research Associates, 3 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".